Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis.

about

Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis.

Item

http://www.wikidata.org/entity/Q50218004

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Yttrium-90 radioembolization t ...... e prognostic factors analysis.

@en

Yttrium-90 radioembolization t ...... e prognostic factors analysis.

@nl

type

Item

label

Yttrium-90 radioembolization t ...... e prognostic factors analysis.

@en

Yttrium-90 radioembolization t ...... e prognostic factors analysis.

@nl

prefLabel

Yttrium-90 radioembolization t ...... e prognostic factors analysis.

@en

Yttrium-90 radioembolization t ...... e prognostic factors analysis.

@nl

P1476

Yttrium-90 radioembolization t ...... re prognostic factors analysis

@en

P2093

A Del Sole

http://www.w3.org/2001/XMLSchema#string

C Masciocchi

http://www.w3.org/2001/XMLSchema#string

D De Palma

http://www.w3.org/2001/XMLSchema#string

F Caspani

http://www.w3.org/2001/XMLSchema#string

F Fontana

http://www.w3.org/2001/XMLSchema#string

G Carrafiello

http://www.w3.org/2001/XMLSchema#string

G Lucignani

http://www.w3.org/2001/XMLSchema#string

S A Angileri

http://www.w3.org/2001/XMLSchema#string

P2860

A prospective evaluation of treatment with Selective Internal Radiation Therapy (SIR-spheres) in patients with unresectable liver metastases from colorectal cancer previously treated with 5-FU based chemotherapy

The role of 90Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic review

Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron

Management of hepatocellular carcinoma: An update

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma: A PRISMA-compliant Systematic Review and Network Meta-analysis

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Hepatocellular carcinoma

New data supporting modified RECIST (mRECIST) for Hepatocellular Carcinoma.

P2888

s12032-017-1021-3

P304

174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-017-1021-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Filippo Pesapane

Chiara Floridi

Antonio Barile

P577

2017-09-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28875374

http://www.w3.org/2001/XMLSchema#string